Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Osteoprotegerin gene polymorphism and therapeutic response to alendronate in postmenopausal women with osteoporosis].

Zhonghua yi xue za zhi - 17 Nov 2009

Wang Chun, He Jin-wei, Qin Yue-juan, Zhang Hao, Hu Wei-wei, Liu Yu-juan, Zhang Zhen-lin

Abstract excerpt

OBJECTIVE: To investigate whether the polymorphism of osteoprotegerin (OPG) gene is associated with the change of BMD (bone mineral density) after alendronate therapy in postmenopausal women with osteoporosis and determine the correlation between genotypes and therapeutic effect. METHODS: Eighty...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alleles
Share to Bone Density

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Osteoporosis, Postmenopausal

Share to Osteoprotegerin

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 20137703

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20137703-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Osteoprotegerin gene polymorphism and therapeutic response to alendronate in postmenopausal women with osteoporosis].PMID 20137703Read ↗

[Polymorphism of osteoprotegerin gene and osteoporosis in postmenopausal women].Semantic proximity Read ↗

[Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women].Semantic proximity Read ↗

Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women.Semantic proximity Read ↗

The effect of A163G polymorphism in the osteoprotegerin gene on osteoporosis related traits in Slovak postmenopausal women.Semantic proximity Read ↗

Association between single nucleotide polymorphisms of the osteoprotegerin gene and postmenopausal osteoporosis in Chinese women.Semantic proximity Read ↗

Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients.Semantic proximity Read ↗

Association between osteoprotegerin genetic variants and osteoporosis in Chinese postmenopausal women.Semantic proximity Read ↗

Influence of the Osteogenomic Profile in Response to Alendronate Therapy in Postmenopausal Women with Osteoporosis: A Retrospective Cohort StudySemantic proximity Read ↗

The influence of osteoprotegerin genetic polymorphisms on bone mineral density and osteoporosis in Chinese postmenopausal women.Semantic proximity Read ↗

Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females.Semantic proximity Read ↗

Associations of osteoprotegerin (OPG) TNFRSF11B gene polymorphisms with risk of fractures in older adult populations: meta-analysis of genetic and genome-wide association studies.Semantic proximity Read ↗

The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.